The signaling axis comprised by the parathyroid hormone (PTH)-related peptide (PTHrP) 
Introduction
During embryonic growth, elongation of epiphyseal cartilage is achieved by both apposition by chondrocyte precursors and interstitial growth performed by chondrocytes in the resting and proliferative zones, which simultaneously proliferate and synthesize cartilage matrix. The length of the resting and proliferative zones of the epiphyseal cartilage is, therefore, determined by the speed of matrix synthesis and proliferation of these chondrocytes, as well as by the speed at which these cells enter their hypertrophic stage.
Parathyroid hormone-related peptide (PTHrP) was originally discovered in tumors that induced the common syndrome of malignancy-associated hypercalcemia (8, 15, 20, 30, 34, 36, 42) .
The N-terminal amino acids of PTHrP share sequence homology with the parathyroid hormone (PTH), which allows both peptides to share a common G protein-coupled receptor, the PTH/PTHrP receptor. Unlike the role played by PTH in maintaining systemic calcium and phosphate homeostasis, PTHrP regulates cell proliferation and differentiation primarily at the local level.
PTHrP and PTH/PTHrP receptor are expressed in chondrocytes throughout the epiphyseal cartilage, and in osteoblasts from the metaphyseal bone (3) . Targeted disruption of PTHrP or PTH/PTHrP receptor in mice resulted in lethal chondrodysplasia, a condition characterized by reduced proliferation and premature hypertrophic differentiation of chondrocytes (2, 18, 21) . These studies suggested that PTH/PTHrP receptor signaling stimulates proliferation of chondrocytes and inhibits their passage to a hypertrophic phenotype in developing cartilage.
Fibroblast growth factor receptor 3 (FGFR3) is another critical mediator of chondrocyte function. Ligand-induced activation of this receptor provokes dimerization, autophosphorylation and activation of intracellular signaling through transduction pathways linked to ras-raf-MEKK, phospholipase-Cγ (PLCγ) and signal transducer and activator of transcription (STAT) (24, 31) . In contrast to PTHrP, FGFR3 has been shown to be a negative regulator of chondrocyte proliferation.
Constitutive activation of FGFR3 is caused by point mutations throughout the receptor, and gives rise to chondrodysplastic disorders such as achondroplasia, hypochondroplasia and thanatophoric 4 dysplasias (25) . Targeted expression of FGFR3 carrying the mutations found in human achondroplasia and thanatophoric induced similar abnormalities in the epiphyseal cartilage of newborn mice (9, 16, 17, 22, 26, 28, 40) .
Thus, PTHrP and FGFR3 have been shown to play critical roles in cartilage and bone development, and may as well interplay during the processes of bone and cartilage development and growth. Chen et al. reported that FGFR3 inhibited PTH/PTHrP receptor expression at the transitional zone that marks the entry point of chondrocytes into a hypertrophic phenotype (10).
The molecular regulation was shown to be mediated through indian hedgehog (IHH), and supported the idea of the existence of a negative feedback on PTH/PTHrP receptor signaling by IHH, a gene that is normally expressed in the hypertrophic zone in vivo.
For in vitro experiments for chondrocyte function, the rat chondrocytic cell line CFK2, established by Bernier et al., is well characterised and broadly used since these cells express PTHrP, PTH/PTHrP receptor and type II collagen (1), and their proliferation was promoted by PTH/PTHrP and epidermal growth factor, but inhibited by dexamethasone and retinoic acid (7). This immortalized cell line, therefore, has properties similar to those of primary proliferating chondrocytes and provides a suitable model for examining the interactions between FGFR3 and PTH/PTHrP signaling.
By employing the CFK2 cell line, in this study, we have examined whether there would be an alternative pathway through which FGFR3 inhibits PTH/PTHrP receptor expression without the mediation of IHH.
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Materials and Methods
Animals and CFK2 cell culture and transfection of cDNAs encoding PTH/PTHrP receptor and FGFR3
A rat chondrocytic cell line, CFK2, which has been previously proven to synthesize type II collagen, PTHrP, PTH/PTHrP receptor (1, 7), was cultured in α minimal essential medium (αMEM, Flow Laboratories, Irvine, Scotland) containing 10% fetal calf serum (FCS) until a confluence of 70% before the transfection. Under Niigata University's guidelines for animal experimentation, the tibiae of newborn Wistar rats were extracted and dissected under a binocular microscope in order to obtain the tissue correspondent to the proximal epiphyseal cartilage. The dissected cartilage pieces were immediately frozen in liquid nitrogen for subsequent RT-PCR. CFK2 cells were cultured at approximately 70% confluence in αMEM. As previously described by Amizuka et al. Germany).
Staining for TUNEL on transfected CFK2 cells
In vitro assessment of cells undergoing apoptosis was performed as described previously, using the ApopTag method (Oncor, Gaithersberg, MD) (6) . The total number of positively stained cells was expressed as a percentage of the total number of cells counted per field, and the results expressed as mean ± SD. Significant differences between control and transfected cells were determined using the unpaired Student's t test. (Fig. 1B) . In addition, lower levels of PTHrP gene were expressed by CFK2 cells transfected with FGFR3 cDNA (Fig. 1C) . In order to quantify the reduction of PTH/PTHrP receptor and PTHrP gene by FGFR3 over-expression, we performed real-time PCR (Fig. 1D) . 
Reduced proliferation and increased apoptosis of CFK2 cells transfected with FGFR3 cDNA
The decrease in PTHrP and PTH/PTHrP receptor expression was accompanied by a significant decrease in the proliferative profile of the transfected cells compared with the control, as evidenced by decreased cell numbers at day 4 after the transfection (29.25 + 5.34 vs 63.50 + 15.96, p<0.05; Fig. 2A ). In addition to decreased proliferative capacity, many transfected CFK2 cells showed TUNEL-positivity compared with the control (Fig. 2B, C) . Statistical analysis demonstrated significant increase of TUNEL-positive cells when transfected with FGFR3 gene after day 3 (Fig.   2D ).
Reduction of PTH/PTHrP receptor gene is mediated by JAK/STAT pathway in CFK 2 cells
Since FGFR3 activation is linked to JAK/STATs and leads to autophosphorylation and translocation of STAT into the nucleus, we have performed a double detection of FGFR3 and STAT1, one of major STATs, in control and FGFR3-expressing CFK2 cells (Fig. 3) . As expected, 
